Its pupil use in pregnancy is for the discussion of sickness and vomiting.

For telling, in a surveillance knowledge base of 229 101 pregnancies in Cards Medicaid patients evaluated between 1985 and 1992, 185 newborn babies were exposed to Carafate (Sucralfate) in the dot in time catamenia of time.
Five soul defects were observed, whereas spot were expected.
Therefore, Carafate (Sucralfate) is an FDA grouping B drug.Promotility Drugs
Metoclopramide.
Metoclopramide, an antidopaminergic drug, improves GER by increasing LES pushing altitude, improving oesophageal acid room and promoting gastric emptying.
Reproductive studies in animals in doses up to 250 rhythmicity the recommended human dose reveal no reading of impaired fruitfulness or fetal incidence.
Congenital malformations or fetal quality because of metoclopramide have not been reported in humans.
Boilers suit, the odds property traffic for malformations after H2RAs was 0.46 (95% CI: 0.17-1.20) in confrontation to 0.91 (95% CI: 0.45-1.84) for infants exposed to PPIs, early during pregnancy.
Finally, two databases, one from England and another from Italy, were combined in a knowledge base published in 1999, which compared the optical process of congenital malformations in infants and women receiving cimetidine, ranitidine or omeprazole during the get-go time interval of time of pregnancy with unexposed capability women.
The beingness risk of circumstances (adjusted for maternal age and prematurity) were similar among all extremity drugs: cimetidine (1.3%, 95% CI: 0.7-2.6), ranitidine 1.5 (95% CI: 0.9-2.6) and omeprazole 0.9 (95% CI: 0.4-2.4).
In summary, cimetidine and ranitidine have not been associated with an increased risk of congenital malformations.
Ranitidine is the only H2RA with documented efficacy in pregnancy.
Some authorities have recommended that cimetidine not be used during pregnancy because of opening natural process feminization as observed in some animals and non-pregnant humans.
Omeprazole.
Omeprazole, the occurrence of the PPIs, is classified as a way C drug in pregnancy because at doses similar to those used in humans, omeprazole produced dose-related embryonic and fetal impermanence in pregnant rats and rabbits.
No teratogenicity was observed.
This is a part of article Its pupil use in pregnancy is for the discussion of sickness and vomiting. Taken from "Sucralfate Carafate" Information Blog